CEI Weekly: FDA Revokes Approval for Breast Cancer Drug

Friday, July 1, 2011

 

 

Featured Video: Greg Conko discusses Avastin on CNBC's Closing Bell.

FEATURED STORY: FDA Revokes Approval for Breast Cancer Drug

 

Avastin is a drug now used by women fighting late-stage breast cancer. This week, an FDA advisory panel voted to revoke approval for Avastin, pointing to clinical studies that show the drug only benefits a small number of patients. CEI Senior Fellow Gregory Conko sharply criticized the FDA's vote when it was announced on Wednesday. Conko earlier penned a Wall Street Journal op-ed and appeared on CNBC's Closing Bell to defend patients' right to choose for themselves whether or not to try Avastin.

 

SHAPING THE DEBATE

 

Why Your New Car Doesn't Have a Spare Tire

Sam Kazman's op-ed in The Wall Street Journal

 

Why Google Probe Should Worry Consumers

Ryan Radia's op-ed in The San Jose Mercury News

 

Multi-State Greenhouse Gas Initiative Violates New York Law, Lawsuit Alleges

CEI's press statement

 

Condemning Our Children to Live in 'Greece'

Iain Murray's op-ed in The Washington Times

 

The USDA's Anti-Science Activism

Greg Conko and Henry I. Miller's article in Regulation

 

Time to Kill the Michigan Alcohol Monopoly

Michelle Minton's op-ed in the Michigan Capitol Confidential News Service

 

Greenhouse Gas Compact Defended in Maine, Challenged Elsewhere

Sam Kazman's citation in The Portland Daily Sun

 

1plusV Lobs Another Antitrust Grenade at Google

Ryan Radia's citation in E-Commerce Times

 

                     

 

CEI PODCAST

 

June 29, 2011: Stealing You Blind

 

Vice President for Strategy Iain Murray’s new book is Stealing You Blind: How Government Fat Cats Are Getting Rich Off of You. He explains why the Washington, DC area is the richest in the country, tells the story of the small-town city manager with a tax-free $1 million per year pension, and offers some reforms that could bring government down to a more appropriate size.